Global Information
회사소개 | 문의 | 비교리스트

세계의 메페리딘(Meperidine) 시장(2020-2026년)

Global Meperidine Market 2020-2026

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949520
페이지 정보 영문
가격
US $ 3,600 ₩ 4,036,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,381,000 Printable PDF (Enterprise License)


세계의 메페리딘(Meperidine) 시장(2020-2026년) Global Meperidine Market 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 메페리딘 시장은 예측기간 중 꾸준한 성장을 나타낼 것으로 예상됩니다. 메페리딘은 Pfizer Inc.에 의해 브랜드명 Demerol로 제공되며, 모르핀과 유사한 오피오이드 클래스 진통제입니다. 따라서 대부분의 국가에서 구입하려면 처방전이 필요합니다. 중등도부터 중증의 통증을 완화시키기 위해 널리 사용되며, 수술 전후나 기타 치료에 사용됩니다. 그러나 이 약물은 장기 또는 진행중인 통증 치료에는 사용되지 않고 돌발적인 통증에서만 사용됩니다.

세계적인 정형외과 수술 증가는 예측기간 중 시장 성장의 주요 요인입니다. 또한 심혈관계, 신경계, 외과수술 증가도 시장 성장을 촉진하고 있습니다. 그러나 구토, 변비, 발한, 어지러움 등의 약물과 관련된 부작용, 대체품의 존재 및 환자에 대한 처방 감소가 시장 성장을 억제하는 몇 개의 요인입니다.

세계의 메페리딘(Meperidine) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 저해요인 분석, 용도·투여 종류·지역별 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요, 시장 기회 등 체계적인 정보를 제공합니다.

목차

제1장 보고서 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트의 인사이트와 현재 시장 동향
  • 규칙과 규제

제3장 경쟁 상황

  • 기업 점유율 분석
  • 주요 전략 분석
  • 주요 기업 분석

제4장 시장 결정요인

  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회

제5장 시장 세분화

  • 용도별
    • 진통
    • 마취
  • 투여 종류별
    • 경구
    • 주사

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양
  • 기타 지역

제7장 기업 개요

  • Boehringer Ingelheim International GmbH
  • Neon Laboratories Ltd.
  • Pfizer Inc.
  • Mallinckrodt plc
  • Hikma Pharmaceuticals PLC
KSM 20.08.18

LIST OF TABLES

  • 1. GLOBAL MEPERIDINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 2. GLOBAL MEPERIDINE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 3. NORTH AMERICAN MEPERIDINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 4. EUROPEAN MEPERIDINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 5. ASIA PACIFIC MEPERIDINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MEPERIDINE MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
  • 2. GLOBAL MEPERIDINE MARKET SHARE BY DOSAGE TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL MEPERIDINE MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. REST OF EUROPE MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. INDIA MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. CHINA MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. JAPAN MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. REST OF ASIA-PACIFIC MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. REST OF THE WORLD MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)

Global Meperidine Market Size, Share & Trends Analysis Report, By Application (Pain Relief, and Anesthesia), By Dosage type (Oral, and Injections) and Forecast, 2020-2026

The meperidine market is expected to show steady growth during the forecast period. It is offered under the brand name Demerol by Pfizer Inc. It is an opioid class analgesic drug, similar to morphine. Due to this, the drug needs a prescription to purchase in most of the countries. It is widely used to relieve a person from moderate to severe pain. Moreover, it is also used during or before surgery or other procedures. However, the drug cannot be used to treat long-term or on-going pain and is used only when the pain is sudden.

Rising cosmetic surgical procedures globally is a major factor for the growth of the market during the forecast period. Moreover, increasing cardiovascular, neurological, surgeries are also motivating the market growth. However, side effects related to the drug such as vomiting, constipation, sweating, lightheadedness, its alternatives available and decrease in the prescriptions to the patients are some of the restraining factors for the market growth.

The global meperidine market is divided on the basis of application and dosage type. Based on application, the market is further bifurcated into pain relief and anesthesia. By dosage type, the market is bifurcated into oral and injections. The market is also studied on the basis of geography. Based on geography, the global meperidine market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to have a major market share. Europe is also expected to hold a considerable market share and Germany, UK, and France will hold a noticeable market share in the region. In addition, Asia-Pacific region is expected to show significant growth during the forecast period. Rising medical tourism, increasing medical surgeries, are some of the major factors motivating the market growth in Asia-Pacific.

Key players acting in the market include Boehringer Ingelheim International GmbH, Neon Laboratories Ltd., Pfizer Inc., Mallinckrodt plc, and Hikma Pharmaceuticals PLC. The market players are adopting growth strategies including mergers & acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global meperidine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Meperidine Market Research and Analysis, By Application
  • Global Meperidine Market Research and Analysis, By Dosage Type

The Report Covers:

  • Comprehensive research methodology of the Global Meperidine Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Meperdine Market.
  • Insights about market determinants which are stimulating the Global Meperidine Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdowns
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Meperidine Market by Application
    • 5.1.1. Pain Relief
    • 5.1.2. Anaesthesia
  • 5.2. Global Meperidine Market by Dosage type
    • 5.2.1. Oral
    • 5.2.2. Injections

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. France
    • 6.2.4. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Boehringer Ingelheim International GmbH
  • 7.2. Neon Laboratories Ltd.
  • 7.3. Pfizer Inc.
  • 7.4. Mallinckrodt plc
  • 7.5. Hikma Pharmaceuticals PLC
Back to Top
전화 문의
F A Q